A Morbidity-Mortality and Remodeling Study With Valsartan

Active, not recruiting

Phase 4 Results N/A

Summary of Purpose

The JIKEI HEART Study has been designed to investigate whether concomitant treatment with valsartan, an angiotensin II receptor blocker (ARB), in addition to conventional treatment, will improve the prognosis of 3000 Japanese patients with cardiovascular diseases.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 October 2005.

1 Jan 2002 22 Aug 2005 Unavailable 1 Nov 2005 1 Jan 2002 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available